Display of functional thrombin inhibitor hirudin on the surface of phage M13

Gene
F WirschingA Schwienhorst

Abstract

A synthetic gene for hirudin was ligated into phagemid pCANTAB5E. This construct allows production of either soluble hirudin or phage having hirudin displayed on the surface. Similarly, hirudin variants with extensions either at their N- or C-terminus were generated. The genes were expressed in their soluble form in a non-suppressor strain of E. coli. Periplasmatic fractions were evaluated in standard thrombin inhibition assays. Extending hirudin by a single Gln residue at the N-terminus reduces the activity by two orders of magnitude. This suggests that either the terminal amine group makes an important interaction or that steric constraints do not allow additional amino acids here. Only C-terminal extensions maintain most of the thrombin inhibitor activity of r-hirudin. The r-hirudin gene was also expressed on the tips of filamentous phage as a fusion protein with protein III (pIII). The hirudin-pIII fusion protein was detected with anti-hirudin antibody and with anti-E-tag antibody by Western blot analysis. Recombinant phages were shown to bind to immobilized thrombin in a dose-dependent manner. Upon addition of soluble thrombin, recombinant hirudin phages could be eluted specifically. Finally, purified phages carrying displ...Continue Reading

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B L RobertsR C Ladner
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R P HarveyJ P Lecocq
Aug 12, 1986·Biochemistry·S R Stone, J Hofsteenge
Apr 1, 1985·Biological Chemistry Hoppe-Seyler·J DodtH Fritz
Oct 29, 1982·Molecular and Cellular Biochemistry·I Björk, U Lindahl
Oct 27, 1995·The Journal of Biological Chemistry·M S DennisR A Lazarus
Sep 14, 1995·Biochemical and Biophysical Research Communications·A S TanakaE A Auerswald
May 1, 1994·Trends in Biotechnology·T Clackson, J A Wells
Oct 1, 1994·Journal of Computer-aided Molecular Design·U EgnerW D Schleuning
Jan 1, 1996·Methods in Enzymology·C I WangC S Craik

❮ Previous
Next ❯

Citations

Oct 3, 1999·European Journal of Immunology·M C ThurnheerB M Stadler
Dec 5, 2003·Molecular Genetics and Metabolism·Frank WirschingAndreas Schwienhorst
May 1, 2001·Biochemical and Biophysical Research Communications·R HempelA Schwienhorst
Mar 27, 2002·Molecular Genetics and Metabolism·Frank WirschingAndreas Schwienhorst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.